Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Cheetham

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Brain Research|September 13, 1988
Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victimsS C Cheetham, M R Crompton, C L Katona, et al.
Neuropharmacology|September 2, 1999
The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortexC J Kettle, S C Cheetham, K F Martin, et al.
Psychiatry Research|November 1, 1988
Brain GABAB binding sites in depressed suicide victimsJ A Cross, S C Cheetham, M R Crompton, et al.
British Journal of Pharmacology|October 24, 1998
A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agentsD J Heal, S C Cheetham, M R Prow, et al.
Brain Research|November 28, 1997
Reduced dopamine turnover in the basal ganglia of depressed suicidesC Bowden, S C Cheetham, S Lowther, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 1998
Dopamine uptake sites, labelled with [3H]GBR12935, in brain samples from depressed suicides and controlsC Bowden, S C Cheetham, S Lowther, et al.
Journal of Neurochemistry|August 1, 1986
Uptake of gamma-aminobutyric acid and glycine by synaptosomes from postmortem human brainJ A Hardy, A Barton, E Lofdahl, et al.
Brain Research|November 20, 1989
Serotonin concentrations and turnover in brains of depressed suicidesS C Cheetham, M R Crompton, C Czudek, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 3, 1998
Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramineD J Heal, S Aspley, M R Prow, et al.
Journal of Affective Disorders|February 1, 1997
5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controlsS Lowther, F De Paermentier, S C Cheetham, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Brain Research|September 13, 1988
Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victimsS C Cheetham, M R Crompton, C L Katona, et al.
Neuropharmacology|September 2, 1999
The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortexC J Kettle, S C Cheetham, K F Martin, et al.
Psychiatry Research|November 1, 1988
Brain GABAB binding sites in depressed suicide victimsJ A Cross, S C Cheetham, M R Crompton, et al.
British Journal of Pharmacology|October 24, 1998
A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agentsD J Heal, S C Cheetham, M R Prow, et al.
Brain Research|November 28, 1997
Reduced dopamine turnover in the basal ganglia of depressed suicidesC Bowden, S C Cheetham, S Lowther, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 1998
Dopamine uptake sites, labelled with [3H]GBR12935, in brain samples from depressed suicides and controlsC Bowden, S C Cheetham, S Lowther, et al.
Journal of Neurochemistry|August 1, 1986
Uptake of gamma-aminobutyric acid and glycine by synaptosomes from postmortem human brainJ A Hardy, A Barton, E Lofdahl, et al.
Brain Research|November 20, 1989
Serotonin concentrations and turnover in brains of depressed suicidesS C Cheetham, M R Crompton, C Czudek, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 3, 1998
Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramineD J Heal, S Aspley, M R Prow, et al.
Journal of Affective Disorders|February 1, 1997
5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controlsS Lowther, F De Paermentier, S C Cheetham, et al.
Pageof 4